4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
6.31
+0.53 (9.17%)
At close: Dec 20, 2024, 4:00 PM
6.62
+0.31 (4.91%)
After-hours: Dec 20, 2024, 4:16 PM EST
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 147 employees as of December 31, 2023. The number of employees increased by 7 or 5.00% compared to the previous year.
Employees
147
Change (1Y)
7
Growth (1Y)
5.00%
Revenue / Employee
$116
Profits / Employee
-$976,054
Market Cap
291.70M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 147 | 7 | 5.00% |
Dec 31, 2022 | 140 | 16 | 12.90% |
Dec 31, 2021 | 124 | 41 | 49.40% |
Dec 31, 2020 | 83 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Canopy Growth | 1,029 |
Cerus | 637 |
CVRx, Inc. | 200 |
Foghorn Therapeutics | 116 |
Sanara MedTech | 108 |
Aclaris Therapeutics | 91 |
Sera Prognostics | 57 |
Candel Therapeutics | 42 |
FDMT News
- 5 weeks ago - 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewsWire
- 6 weeks ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Encourages Investor Participation - Accesswire
- 6 weeks ago - Shareholders Are Invited To Join The Schall Law Firm In An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire
- 7 weeks ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Reach Out - Accesswire
- 7 weeks ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out - Accesswire
- 7 weeks ago - 4D Molecular Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Investors To Take Part - Accesswire
- 7 weeks ago - Shareholders Are Encouraged To Join The Schall Law Firm In An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire
- 2 months ago - Shareholders Are Encouraged To Join An Inquiry Into 4D Molecular Therapeutics, Inc. For Securities Law Violations - Accesswire